Milestone Scientific (NYSE:MLSS) shares rose today after the company said it won marketing clearance in Saudi Arabia, weeks after winning a regulatory nod in Australia for its epidural and intra-articular instruments.
The company’s CompuFlo Epidural instrument uses dynamic pressure sensing to help anesthesiologists correctly identify the epidural space and significantly reduce complications, according to Milestone. The CompuFlo Intra-Articular instrument also features dynamic pressure sensing for precise computerized drug injections into intra-articular joint spaces for patients with osteoarthritis.
Get the full story at our sister site, Drug Delivery Business News.